ORTX
$0.88
Orchard Therapeutics Plc ADR
($.01)
(.77%)
ORTX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.29)
Revenue:  $1.50 Mil
Tuesday
Mar 1
7:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ORTX reports earnings?
Beat
Meet
Miss

Where is ORTX's stock price going from here?
Up
Flat
Down
Stock chart of ORTX
Analysts
Summary of analysts' recommendations for ORTX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom.